THC Stock Recent News

Investors need to pay close attention to THC stock based on the movements in the options market lately.

Tenet Healthcare Corporation THC posted better-than-expected earnings for the second quarter on Tuesday.

Tenet Healthcare remains a buy, consistently beating earnings and raising guidance, even as the healthcare sector faces broad pressure from looming Medicaid cuts. Ambulatory segment growth is key, as it is higher margin and less exposed to Medicaid risk than the hospital segment, which faces headwinds post-2026. Medicaid cuts are now law and will hit hardest after 2026, posing significant long-term risk to hospital revenues despite Tenet's restructuring efforts.

Tenet Healthcare Corporation (NYSE:THC ) Q2 2025 Earnings Conference Call July 22, 2025 10:00 AM ET Company Participants William McDowell - Vice President of Investor Relations Saumya Sutaria - Chairman & CEO Sun Park - Executive VP & CFO Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Joshua Raskin - Nephron Research LLC Andrew Mok - Barclays Bank PLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Justin Lake - Wolfe Research, LLC Sarah James - Cantor Fitzgerald & Co., Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Pito Chickering - Deutsche Bank AG, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Ryan Langston - TD Cowen, Research Division John Ransom - Raymond James & Associates, Inc., Research Division Kevin Fischbeck - BofA Securities, Re

Tenet Healthcare (THC -10.70%), the healthcare operator with a large network of hospitals and ambulatory surgery centers, reported earnings for Q2 2025 on July 22, 2025. The most notable result: adjusted earnings per share (EPS) soared to $4.02 (non-GAAP) -- well above Wall Street expectations of $2.87 (non-GAAP).

THC's Q2 earnings benefit on the back of strong volumes, facility buyouts, higher acuity and favorable payer mix. It currently expects 2025 adjusted EPS within $15.55-$16.21, up from the earlier view of $11.99-$13.12.

While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Tenet Healthcare (THC) came out with quarterly earnings of $4.02 per share, beating the Zacks Consensus Estimate of $2.84 per share. This compares to earnings of $2.31 per share a year ago.

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended June 30, 2025. "Our strong second quarter results extend our track record of attractive same store revenue growth, operational performance driven by fundamentals, and robust free cash flow generation," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We continue to make investments both organically and inorganically to expand our capabilities and in.

HCA, THC, UHS, and CYH are showing strength through smart expansions and solid earnings despite hospital industry headwinds.